Evidence map›Paper›PMID 41423697›Full record

ArticleTranslational neurodegeneration2025

Cortical layer multi-parameter analysis of neurovascular impairments in AD/ADRD rodent model with in vivo optical imaging.

Hyomin Jeong, Jiaxiang Ren, Wensheng Cheng, Nora D Volkow, Haibin Ling, Donghui Zhu, Congwu Du, Yingtian Pan

Abstract read
In one paragraph

Article in Translational neurodegeneration, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hyomin JeongDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794, USA.ORCID http://orcid.org/0009-0005-9970-7069
Jiaxiang RenDepartment of Computer Science, Stony Brook University, Stony Brook, NY, 11794, USA.
Wensheng ChengDepartment of Computer Science, Stony Brook University, Stony Brook, NY, 11794, USA.
Nora D VolkowNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20857, USA.
Haibin LingDepartment of Computer Science, Stony Brook University, Stony Brook, NY, 11794, USA.
Donghui ZhuDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794, USA.
Congwu DuDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794, USA.
Yingtian PanDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794, USA. yingtian.pan@stonybrook.edu.ORCID http://orcid.org/0000-0002-7635-1443

Funding

Calcium-related Neurotoxicity of CocaineR01DA029718 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI DU, CONGWU, PAN, YINGTIAN · 2012 to 2025
$4.2M
Molecular Mechanism and Functional Role of Magnesium in Neuroinflammation in Alzheimer's DiseaseR01AG064798 · NIA · STATE UNIVERSITY NEW YORK STONY BROOK · PI ZHU, DONGHUI · 2019 to 2023
$3.6M
Neuro-glio-vascular interactions in vivo probed with optical imagingRF1DA048808 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI DU, CONGWU, PAN, YINGTIAN · 2019 to 2019
$1.2M
Imaging neural, astrocytic and vascular synchronization to assess cocaine's effects on mPFCR21DA057699 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI DU, CONGWU, LING, HAIBIN · 2023 to 2024
$416k
Optical platform to image neuronal and vascular effects of cocaine in awake rodentsR21DA042597 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI DU, CONGWU, PAN, YINGTIAN · 2016 to 2017
$392k
National Institute of Health 2R01 DA029718National Institute of Health R01AG064798National Institute of Health R21DA042597NIA NIH HHS R01 AG064798NIDA NIH HHS R01 DA029718NIDA NIH HHS R21 DA042597NIDA NIH HHS R21 DA057699NIDA NIH HHS RF1 DA048808
6 · The paper itself

Abstract

backgroundNeurovascular biomarkers have the potential to enhance early diagnosis of Alzheimer's disease (AD) and AD-related dementias (ADRD), as cerebrovascular alterations often precede neurodegeneration. However, their clinical application remains challenging due to insufficient specificity, heterogeneity, and technical limitations.

methodsHere, we report that vessel- and cortical layer-specific parameters exhibit promising diagnostic sensitivity for neurovascular impairments in an AD/ADRD mouse model, apolipoprotein E (APOE) 4 knock-in (KI), compared to APOE3-KI at 12 months of age. Using two in vivo imaging modalities, 3D capillary-resolution optical Doppler tomography and laser speckle contrast imaging, we measured 36 morphological and functional vascular parameters and evaluated their diagnostic performance using a machine-learning Support Vector Machine classifier.

resultsAPOE4 mice showed significant alterations including reduced venular and arterial cerebral blood flow velocities and diameters, increased vascular tortuosity, layer-dependent decreases in vascular density, and impaired cerebrovascular reactivity. Venule- and microcirculation-related parameters and dynamic vasoactivity to brain stimuli demonstrated high diagnostic accuracy (~ 90%).

conclusionTogether, these findings provide in vivo evidence for early, cortical layer-specific neurovascular dysfunction caused by APOE4 that increases the susceptibility to dementia and highlight the potential of combining neurovascular biomarkers from optical imaging with AI-based classifier for identification of increased AD/ADRD risk.

Indexed as

Alzheimer DiseaseCerebral CortexCerebrovascular CirculationOptical ImagingAnimalsApolipoprotein E4Disease Models, AnimalMaleMiceMice, TransgenicApolipoprotein E4AI-based classifierAlzheimer’s diseaseApolipoproteinBiomarkersCerebral vasculatureDementiaEarly diagnosisLaser speckle contrast imagingNeurovascular dysfunctionOptical coherence tomographyOptical imaging

Identifiers

PMID41423697
PMCPMC12720472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.